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Advanced gastric cancer is often accompanied by metastasis to the peritoneum, resulting in a high mortality rate. Mechanisms
involved in gastric cancer metastasis have not been fully clariﬁed because metastasis involves multiple steps and requires a
combination of altered expressions of many different genes. Thus, independent analysis of any single gene would be
insufﬁcient to understand all of the aspects of gastric cancer peritoneal dissemination. In this study, we performed a global
analysis of the differential gene expression of a gastric cancer cell line established from a primary main tumour (SNU-1) and of
other cell lines established from the metastasis to the peritoneal cavity (SNU-5, SNU-16, SNU-620, KATO-III and GT3TKB).
The application of a high-density cDNA microarray method made it possible to analyse the expression of approximately
21168 genes. Our examinations of SNU-5, SNU-16, SNU-620, KATO-III and GT3TKB showed that 24 genes were up-
regulated and 17 genes down-regulated besides expression sequence tags. The analysis revealed the following altered
expression such as: (a) up-regulation of CD44 (cell adhesion), keratins 7, 8, and 14 (epitherial marker), aldehyde
dehydrogenase (drug metabolism), CD9 and IP3 receptor type3 (signal transduction); (b) down-regulation of IL2 receptor g,
IL4-Stat (immune response), p27 (cell cycle) and integrin b4 (adhesion) in gastric cancer cells from malignant ascites. We then
analysed eight gastric cancer cell lines with Northern blot and observed preferential up-regulation and down-regulation of
these selected genes in cells prone to peritoneal dissemination. Reverse transcriptase–polymerase chain reaction conﬁrmed
that several genes selected by DNA microarray were also overexpressed in clinical samples of malignant ascites. It is therefore
considered that these genes may be related to the peritoneal dissemination of gastric cancers. The results of this global gene
expression analysis of gastric cancer cells with peritoneal dissemination, promise to provide a new insight into the study of
human gastric cancer peritoneal dissemination.
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Gastric cancer is the most frequent malignancy of the gastroin-
testinal tract among Japanese and certain South-East Asian
populations and the second most common cause of cancer-
related death in the world (Parkin et al, 1999). The prognosis
of gastric cancer has been improving owing to progress in diag-
nostic techniques and treatment methods for gastric cancer, but
peritoneal dissemination is the main cause of recurrence after
curative resection of advanced cancer. The prognosis of gastric
cancer which has invaded as far as the gastric serosa is still poor
with a 5-year survival of less than 35% (Yamazaki et al, 1989;
Shimada and Ajani, 1999). Among these malignant characteristics
of gastric cancer cells, metastasis to the peritoneum is an espe-
cially complex phenomenon, which requires the involvement of
many different genes in multiple steps for tumour cells. Although
many aspects of gastric cancer metastasis await further clariﬁca-
tion, adhesion molecules, apoptosis-related genes, and others
have been reported to play an important role in peritoneal disse-
mination of gastric cancers (Tahara et al, 1996; Yawata et al,
1998; Tahara, 2000). It is well known that changes in the expres-
sion of these genes enhance cell escape from the primary tumour
and resistance to apoptosis, but details of the mechanism
involved remain unclear.
Most gastric cancer cell lines have been established from liver
metastases, lymph node metastases, or malignant ascites, while
few have been established from primary lesions. To investigate
the mechanism of gastric cancer peritoneal dissemination, Park et
al (1990, 1994) established several gastric cancer cell lines, SNU-
1, SNU-5, SNU-16, and SNU-620 cells, SNU-1 from primary
tumour, and others from malignant ascites, which have a high
potential for peritoneal dissemination. SNU cell lines have been
studied both extensively and intensively. cMET is ampliﬁed in
SNU-16, overexpression of TGF-b type II receptor, CEA, CA19-9,
and c-erbB 2 has been conﬁrmed in SNU-1, SNU-5 and SNU-
16, KATO-III cells have K-sam ampliﬁcation (Katoh et al, 1992),
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www.bjcancer.comand GT3TKB reduced expression of E-cadherin (Tamura et al,
1996). But their common changes of gene expression have not
yet been clariﬁed.
Coordination of multiple genes is involved in metastasis,
whereas only one gene or a few genes have been the subject of
most previous reports on metastasis. Moreover, differences in
metastatic potential are expected to be due to a combination of
differently expressed genes. In this context, gene expression analysis
of gastric cancer cells with different metastatic potentials in terms
of grade and target is extremely relevant for the clariﬁcation of the
mechanism of gastric cancer peritoneal dissemination. For this
study, we performed globally analysed expression proﬁles of
approximately 21000 genes in SNU-1, SNU-5, SNU-16, SNU-
620, KATO-III, and GT3TKB cells by using a cDNA microarray.
By combining this analysis with subsequent conﬁrmation of altered
expressions of selected genes by Northern blot analysis or RT–
PCR, differently expressed genes among these cells could be posi-
tively identiﬁed. Although further functional analysis is necessary,
our results can be expected to prove new insights into the mechan-
ism of gastric cancer metastasis.
MATERIALS AND METHODS
Cell culture and RNA preparation
Gastric cancer cell lines SNU-1, SNU-5, SNU-16, SNU-620 cells
were established previously by Park et al (1990, 1994, 1997).
KATO-III, GT3TKB and MKN 7 were purchased from Riken Cell
Bank (Tsukuba, Japan) (Hojo, 1977; Sekiguchi et al, 1978; Tamura
et al, 1996). NUGC-3 cells were purchased from Health Science
Research Resources Bank (Osaka, Japan). GT3TKB were main-
tained at 378C in a humidiﬁed atmosphere of 5% CO2 in high-
glucose DMEM (Sigma, St. Louis, MO, USA), whereas MKN7
and NUGC-3 were maintained in RPMI 1640 (Sigma). Both media
were supplemented with 10% foetal bovine serum, penicillin, and
streptomycin. When they reached 80–90% conﬂuence, cells were
washed with ice-cold PBS and homogenised immediately. mRNA
extracted from each cell line was extracted by FAST track kit
Ver.2 (Invitrogen) according to the manufacturer’s instructions.
Characteristics of these gastric cancer cell lines (origin, histology,
potency of intraperitoneal transplantation) are shown in Table 1.
Experimental model in nude mouse
Four-week-old female BALB/c nu/nu mice (Clea Japan, Inc., Osaka,
Japan) were inoculated intraperitoneally with 5610
6 gastric cancer
cells in 0.5 ml PBS. Four weeks later, the presence of disseminated
foci or ascites was determined. All animal experiments were
conducted in accordance with institutional guidelines for animal
welfare.
Preparation of probe
One microgram of mRNA extracted from each gastric cancer cell
line was labelled by incorporating Cy3 during random-primed
reverse transcription. cDNA derived from the reference pool, which
we labelled with Cy5, was used as the expression reference. We
combined mRNA from the following cells in equal quantities to
make the reference pool: HL60 (acute myeloid leukaemia) and
K562 (chronic myeloid leukaemia); NCI-H226 (non-small cell
lung); COLO205 (colon); SNB-19 (central nervous system); LOX-
IMVI (melanoma); OVCAR-3, OVCAR-4 (ovary); CAKI-1
(kidney); PC-3 (prostate); and MCF7 and HS 578T (breast).
Twelve highly diverse cell lines were selected on the basis of the
results of previous studies (Ross et al, 2000; Scherf et al, 2000). Cell
lines were selected from various organs to ensure that the reference
RNA contained as many different kinds of gene transcripts as
possible.
The labelling was carried out at 428C for 1 h in a total volume
of 30 ml containing 400 units of SuperScript II (GIBCO/BRL);
0.1 mM Cy3-dUTP (or Cy5-dUTP); 0.5 mM each dATP, dCTP,
and dGTP; 0.2 mM dTTP, 10 mM DTT, 6 mlo f5 6ﬁrst-strand
buffer, and 6 mg of random primers. To remove unincorporated
nucleotide, labelled cDNA was mixed with 500 ml of binding buffer
(5 M guanidine thiocyanate per 10 mM Tris×HCl, pH 7.0 per
0.1 mM EDTA containing 0.03% gelatin and 2 ng ml
71 tRNA)
and 50 ml of silica matrix buffer (10% matrix/3.5 M guanidine
hydrochloride/20% glycerol/0.1 mM EDTA/200 mM NaOAc,
pH 4.8–5.0), transferred to a GFX column (Amersham Pharma-
cia), and centrifuged at 15000 r.p.m. in a Sorvall centrifuge (RC-
3B plus; H6000A/HBB6 rotor) for 30 s. The ﬂow-through was
discarded, and the column was washed with 500 ml of wash buffer.
The adsorbed probe was eluted into a ﬁnal volume of 17 mlo f
distilled water. This labelled probe was mixed with blocking solu-
tion containing 3 mlo f1 0mg ml
71 oligo(dA), 3 mlo f2 0mg ml
71
yeast tRNA, 1 mlo f2 0 mg ml
71 mouse Cot1 DNA, 5.1 mlo f
206SSC, and 0.9 ml 10% SDS (Miki et al, 2001).
Array hybridisation and data analysis
The RIKEN human cDNA that comprised the target was hybridised
in a ﬁnal volume of 30 ml; the entire array consists of three multi-
blocks, and each multiblock required 10 ml of hybridisation
solution. Before hybridisation, probe aliquots were heated at
958C for 1 min and cooled at room temperature. Coverslips were
hybridised overnight at 658C in a Hybricasette (obtained from
ArrayIt.com). After hybridisation, slides were washed in 26SSC/
0.1% SDS until the coverslips dropped off, and the slides were then
transferred into 16SSC, shaken gently for 2 min, and rinsed with
0.16SSC for 2 min. After washing, slides were spun at 800 r.p.m.
in a Sorvall centrifuge (RC-3B plus; H6000A/HBB6 rotor). These
slides were scanned on a ScanArray 5000 confocal laser scanner,
and the images were analysed by using IMAGENE (BioDiscovery;
Los Angeles, CA, USA).
Analysis of the data
To improve the accuracy of the data, we did the experiment twice,
labelling the same RNA template in two separate reactions. Data
were normalised to the reference standard by subtracting (in log
space) the median observed value if it were other than zero. We
used only data points that were reproducible. To this end, we
developed a ﬁltering program, PRIM (Kaota et al, 2001). Brieﬂy,
this program (i) deletes the results with ‘ﬂags’ added manually to
corrupted spots; (ii) eliminates spots with signal intensities less
than the mean + 36standard deviation of the background signal
intensity in either Cy3 or Cy5; and (iii) eliminates spots located
outside the least-mean-squares line +26standard deviation. After
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Table 1 Characteristics of gastic cancer cell lines
Transplantation
Cell line Origin Histology in peritoneal cavity
SNU-1 Primary tumor Poorly diff. adenoca. Impossible
SNU-5 Malignant ascites Poorly diff. adenoca. Possible
SNU-16 Malignant ascites Poorly diff. adenoca. Possible
SNU-620 Malignant ascites Poorly diff. adenoca. Possible
KATO-III Pleural effusion Signet ring cell carcinoma Possible
GT3TKB Malignant ascites Moderately diff. adenoca. Possible
MKN7 Lymhode metastses Well diff. adenoca Impossible
NUGC3 Lymhnode metastses Poorly diff. adenoca. Impossible
The characteristics comprise origin, histology and potency of intraperitoneal
transplantation.
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experiments by calculating a Pearson’s correlation coefﬁcient. If
the coefﬁcient was equal to or greater than 0.7, we used the data
in subsequent analyses. If not, we repeated the labelling, hybridisa-
tion, and scanning up to six times. In this way, we could generate
high-quality data for most tissues. Preceeding the clustering, ratio
values from duplicate experiments were averaged, log-transformed
(base 2), and stored in a table. We applied hierarchical clustering
to both axes, using the weighted pair-group method with a
centroid average as implemented by the program CLUSTER (Eisen
et al, 1998). The results were analysed by using TREEVIEW (Eisen
et al, 1998).
Northern blot analysis
Northern blot was performed as we described previously (Sakakura
et al, 1994, 1996). In brief, total cellular RNA was prepared by the
guanidine isothiocyanate-phenol-chloroform procedure. Selection
of poly(A)
+ RNA was performed by an oligo dT column, then frac-
tionated on 1% agarose/2.2 M formaldehyde gels. Probes were
labelled with
32P by random priming. Each blot was hybridised
with probes for each selected gene and b-actin. We analysed signals
with a BAS 2000 image analyser and calculated the degree of over-
expression compared to control.
Clinical samples of malignant ascites and peritoneal washes
of benign disease
The study population is consist of 10 patients of gastric cancer with
malignant ascites (with positive cytology results) and 10 patients
with benign disease including cholecystolithiasis and leiomyoma
of the stomach, undergoning surgery at Kyoto Prefectural Univer-
sity of Medicine. Ascites ﬂuid was collected from the Douglas
cavity at laparotomy. In the absence of ascites, 50 ml of saline
was introduced into the Douglas cavity at the beginning of the
operation and aspirated after general stirring. These washes were
centrifuged at 2000 r.p.m. for 10 min to collect intact cells, rinsed
with PBS, dissolved in ISOGEN RNA extraction buffer (Nippon
Gene, Tokyo), and stored at –808C until use. All experiments with
clinical samples were conducted under institutional guideline from
the Ministry of Health and Welfare.
Reverse transcriptase–polymerase chain reaction
(RT–PCR)
cDNA was produced from total RNA by using a Superscript
preampliﬁcation system (BRL, Bethesda, MD, USA) and following
the procedures suggested by the manufacturer. RNA was heated to
658C for 10 min in 14 ml of duethylpyrocarbonate-treated water
containing 0.5 mg oligo (dT). Synthesis buffer (106), 2 ml
10 mM dNTP mix, 2 ml 0.1 M DTT, and reverse transcriptase
(Superscript RT; 200 U ml
71) were added to the sample. The
resulting reaction mixture was incubated at 428C for 50 min, and
reaction was terminated by incubating the mixture at 958C for
5 min.
The sequences of the three sets of primer used were: Inositol
triphospate receptor (IP3R) (sense) 5'-CACGTGAAGTGGGCCA-
TAAC-3', (antisense) 5'-TCCGTCAGGAACTGGCAGAT-3';
Keratin 7 (sense) 5'-ACCATTAACCAGAGCCTGCT-3', (antisense)
5'-TCATTCAGGGCATCCACCTT-3'; aldehyde dehydrogenase
(ALDH) (sense) 5'-ATTGTGTTAGCTGATG CCGACTT-3' (anti-
sense) 5'-CACTGGCCCTGGTGGTAGAATA-3'. PCR was carried
out in a reaction mixture (10 ml) containing 10 mM Tris-HCl,
pH 8.3, 50 mM KCl, 200 mM dNTP, 1.5 mM MgCl2, 0.25 unit of
Taq DNA polymerase (Perkin-Elmer Cetus, Branchburg, NJ,
USA), 0.2 mM primers A and B, and 1 ml of template cDNA.
Twenty-ﬁve rounds of ampliﬁcation were performed in a thermo-
cycler (MJ Research Inc., Watertown, MA, USA) at 948C for 30 s,
588C for 30 s, and 728C for 30 s, with a ﬁnal extension step at
728C for 10 min. After PCR, 5 ml of the reaction mixture was elec-
trophoresed on a 2% agarose gel.
RESULTS
Global gene expression analysis by cDNA microarray of
gastric cancer cell lines from malignant ascites
We performed a global analysis of gene expression of 21168 genes
in SNU-1, SNU-5, SNU-16, SNU-620, KATO-III and GT3TKB cells
using a high-density cDNA microarray and compared the gene
expression proﬁles of SNU-5, SNU-16, SNU-620, KATO-III and
GT3TKB cells with that of SNU-1. To eliminate data with low
reliability, genes whose expression was regarded as absent in both
cell lines as a result of software analysis were excluded. The results
of the analysis by TREEVIEW are shown in Figure 1. Among the
11680 to 15151 genes (known genes and ESTs) expressed, 44 genes
showed a differential expression more than double that of SNU-1
and 30 more than half that of other cell lines. To verify these ﬁnd-
ings, we performed Northern blot to analyse all these genes that
showed greater than two-fold difference in terms of cDNA array.
When more than two-fold changes in expression level by Northern
blot analysis were considered signiﬁcant, consistency with cDNA
microarray analysis were 55% (41 of 74), whereas no signiﬁcant
change was seen in 27% (20 of 74), and discordant results were
obtained in 18% (13 of 74). Genes identiﬁed both analyses are
listed in Tables 2 and 3. Typical data are shown in Figures 2
and 3.
Expression of selected genes in eight gastric cancer cell
lines
Because the peritoneal dissemination potentials of other gastric
cancer cell lines have been reported by several previous studies,
we also investigated the expression of the differential gene expres-
sion of SNU-1 and other gastric cancer cells by Northern blot
analysis. We performed this analysis on another two gastric cancer
cell lines in addition to the six cell lines analysed by cDNA micro-
array, to ﬁnd any correlation between these genes and the
peritoneal dissemination potential of gastric cancer cells (Figures
2 and 3). KATO-III, SNU-5, SNU-16, and SNU-620 are often used
as a peritoneal dissemination model in nude mice because of their
reportedly high potential for peritoneal dissemination. Although
there are no reports on this potential of GT3TKB in nude mice,
we conﬁrmed it in an animal experiment, in which NUGC-3 and
MKN7 did not generate a peritoneal metastasis even 4 weeks after
inoculation. These ﬁndings indicated that these cells can be readily
classiﬁed into three groups: (a) cells with a high potential for peri-
toneal dissemination (SNU-5, SNU-16, and SNU-620, KATO-III
and GT3TKB), (b) main tumour-derived cell line SNU-1 with no
potential for peritoneal dissemination and (c) MKN7 and
NUGC-3 with low potential or no potential for peritoneal dissemi-
nation.
In addition to MKN7 and NUGC3, most genes, CD44 and
Keratin family genes are strongly expressed in gastric cancer cells
of peritoneal dissemination. Several genes, such as aldehyde dehy-
drogenase and IP3R, showed a high expression level only in cells
with a high potential for such dissemination and a low expression
level in all of the cells with a low potential for peritoneal dissemi-
nation. These changes in expression may be speciﬁc for gastric
cancer peritoneal dissemination. Most down-regulated genes, such
as p27 are also repressed in all other gastric cancer cell lines,
while some of the listed genes, such as IL4 Stat, are more inten-
sively down-regulated in gastric cancer cells of peritoneal
dissemination.
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(10), 1153–1161Experimental model in nude mouse
Intraperitoneal inoculation of KATO-III or GT3TKB cells resulted
in nodules in the peritoneal cavity, while the other cell lines, SNU-
5, SNU-16, and SNU-620, formed nodules and malignant ascites.
In contrast, no disseminated foci could be detected after intraper-
itoneal inoculation of either MKN7 or NUGC3. Potency of
intraperitoneal transplantation in these cancer cells is shown in
Table 1.
RT–PCR
A speciﬁc PCR fragment was successfully ampliﬁed by RT–PCR
for each set of primers with the expected size. Direct sequencing
conﬁrmed that these bands could be identiﬁed with each of the
ampliﬁed sequences. The speciﬁc band was detected in all ten
samples of malignant ascites tested with each of three different
target genes. In contrast, none of the 10 patients with benign
disease was positive, although shallow bands were detected in
some of them. Typical data are shown in Figure 4. These results
suggest that genes selected by DNA microarray were overexpressed
in the gastric cancer cell lines established from the metastases to
the peritoneal cavity as well as in the clinical samples of malignant
ascites.
DISCUSSION
The introduction of novel improved array technologies has resulted
in new possibilities for studying the molecular mechanisms of
cancer metastasis. In our study, the relative mRNA levels of genes
expressed in the cell lines examined were identiﬁed by using cDNA
microarrays. The array analysis suggested that the genes shown in
Table 2 were up-regulated and those in Table 3 were signiﬁcantly
down-regulated. With regard to peritoneal dissemination, malignant
characteristics of cancer cells such as reduced intercellular adhesion,
increased cell-to-matrix adhesion, and resistance to apoptosis are
considered to be important features. Several of the 41 genes that
showed different expression levels in SNU-1 and other cell lines
different from those of malignant ascites have been previously
reported to be related to these features. The possible involvement
of other genes listed in Tables 2 and 3 to peritoneal dissemination
of gastric cancers has not yet been reported. Other expression
sequence tags (ESTs) can be expected to be involved in peritoneal
dissemination, but the precise function of each gene remains
unclear, so that further study would be necessary to clarify it.
Previous reports have shown gene expression proﬁles in schir-
rous gastric cancer cell lines as well as xenografts of gastric
cancers in nude mice (El-Rifai et al, 2001; Hippo et al, 2001). As
we screened more than 21000 genes, we could select more novel
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Figure 1 High-density cDNA microarray analysis. Validation in expression of selected genes from 21 68 clones in six gastric cancer cell lines. Data are
represented in a matrix format: each row represents a single gene, and each column an experimental sample. In each sample, the ratio of the number of
transcripts of each gene to the medium abundance of the gene’s transcript among all the cell lines is represented by the colour of the corresponding celli n
the matrix. Green square,transcript level below the median; black squares, transcript levels equal to the medium; red squares, transcript levels greater than
the median. Colour saturation reﬂects the magnitude of the ratio relative to the median for each set of samples. (A) Cluster analysis of selected genes of six
gastric cancer cell lines using the RIKEN cDNA microarray. Bars to the right identify the location of the inserts displayed in panels B and C.( B) Up-regulated
genes in gastric cancer cells from malignant ascites. (C) Down-regulated genes in gastric cancer cells from malignant ascites
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genes of Tables 2 and 3 were singled out according to their func-
tion and are discussed in relation to previous reports.
Genes related to signalling (growth and metabolism)
Although growth factors, their ligands and down-stream molecules
are frequenly overexpressed in cancer cells, to the best of our
knowledge, several genes related to signalling as listed in Table 2,
have not been reported previously. The extracellular domain of
CD9 binds the epidermal growth factor (EGF) and enhances the
function of EGF signalling (Nakamura et al, 2000; Hashida et al,
2002). Dopa decarboxylase (DDC) is responsible for the synthesis
of the key neurotransmitters dopamine and serotonin, and is
frequently expressed in neuroblastoma and small cell carcinoma
of the lung (North and Du, 1998; Gilbert et al, 1999). Sodium/
hydrogen exchanger isoform 1, is activated more in malignant glio-
mas than nontransformed astrocytes, and malignant gliomas
display altered pH regulation (Lagana et al, 2000; McLean et al,
2000). LMO7 in gastric cancer has not been dealt with in any
reports, but another isoform, LMO4 (a transcriptional regulator)
inhibits differentiation of mammary epithelial cells in vitro and is
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Table 2 Up-regulated genes in gastric cancer cells from malignant ascites in comparison to those from primary lesion
Gene bank Northern Gene chip
No. (accession) blot (mean) (mean) Gene name Function
1 AA486275 3.2 3.63 Leukocyte elastase inhibitor Apoptosis
2 AA446222 5.7 4.29 TGFb-induced antiapoptotic factor Apoptosis
3 AA424695 2.3 2.14 Integrin alpha3 Cell adhesion
4 AA444051 3.3 2.58 S100 A10 (ligand of Annexin II) Cell adhesion
5 AA630328 4.3 6.02 Galectin 3 (lectin) Cell adhesion
6 H94471 2.1 7.84 Occludin Cell adhesion
7 AA282906 6.5 9.58 CD44 Cell adhesion
8 R33456 7.3 15.89 Desmoplakin (DPI, DPII) Cell adhesion
9 H44051 6.5 10.48 Keratin 14 Cell adhesion, invasion
10 AA598517 15.9 13.64 Keratin 8 Cell adhesion, invasion
11 AA489569 10.3 25.63 Keratin 7 Cell adhesion, invasion
12 R93124 15.3 24.08 Aldo-keto reductase family 1 Drug metabolism
13 AA664101 14.7 33.13 Aldehyde dehydrogenase Drug metabolism
14 N77779 2.5 5.78 Renal tumour antigen RAGE1 Immune response
15 AA424824 3.1 4.29 Destrin (actin depolymerising factor) Interaction with extracellular matrix
16 AA625890 3.8 7.46 Myosin 6 Intracellular organelle transport
17 AA425938 3.1 2.3 Cystein protease (legumain) Invasion
18 H22826 4.1 5.66 LMO 7 Signalling
19 AA496691 5.1 6.19 Dystroglycan1 Signalling
20 AA455369 4.2 2.55 Sodium/hydrogen exchanger, isoform 1 Signalling
21 AA281735 11.4 15.56 Inositol triphosphate receptor Signalling
22 AA412053 7.8 16.34 CD9 Signalling
23 AA25319 3.1 2.27 Caveolin-3 Signalling (modiﬁcation)
24 AA702640 7.6 11.08 Dopa decarboxylase Signalling or progression
GenBank accession number, fold change veriﬁed by high-density oligonucleotide array and Northern blot, and one representative function of the genes as previously reported
are shown. Only the genes that showed more than two-fold change in expression by cDNA array and greater than two-fold by Northern blot are listed, and genes are sorted by
Northern blot data
Table 3 Down-regulated genes in gastric cancer cells from malignant ascites in comparison to those from primary lesion
Gene bank Northern Gene chip
No. (accession) blot (mean) (mean) Gene name Function
1 AA453105 0.5 0.29 H2A histone family member L Apoptosis
2 AA025275 0.3 0.35 Death associated protein Apoptosis
3 AA485668 0.3 0.37 Integrin b4 Cell adhesion
4 H37989 0.2 0.52 Tubulin beta-1 chain Cell structure
5 T97593 0.2 0.37 Heterogenous nuclear ribonucleoprotein Cell structure
6 T64150 0.4 0.46 RAD51 homologue C Chromosome stability
7 H79047 0.3 0.16 IGFBP2 Growth and metabolism
8 N75745 0.2 0.09 IL2 receptor gamma Immune response
9 AA476285 0.2 0.37 CD4 Immune response
10 T72202 0.3 0.46 IL4 stat Immune response
11 AA236617 0.4 0.37 PAK-interacting exchange factor alpha Signalling
12 AA630082 0.1 0.41 p27kip Signalling
13 AA629692 0.3 0.46 Chaperonin containing TCP1 Signalling
14 W46769 0.2 0.61 Histone deacetylase 3 Signalling
15 AA485214 0.2 0.22 Nucleobinding 2 Signalling (apoptosis)
16 W86653 0.1 0.11 FKBP54 Signalling
17 H96140 0.2 0.43 Acyl-Coenzyme A dehydrogenase Signalling
GenBank accession number, fold change veriﬁed by high-density oligonucleotide array and Northern blot, and one representative function of the genes as previously reported
are shown. Only the genes that showed expression change greater than two-fold by cDNA array and greater than two-fold by Northern blot are listed, and genes are sorted
according to Northern blot data.
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(10), 1153–1161overexpressed in breast cancers (Putilina et al, 1998; Kurihara et al,
2002). Inositol 1, 4, 5-triphospate receptor type 3 (IP(3)R3) is
frequently expressed in secretion cells and known to be related
to the IP3 signalling pathway, Ca
2+ inﬂux, enzyme secretion and
cell motility (Broad et al, 2001; Lee and Laychock, 2001), but its
role in peritoneal dissemination is still unclear. Aldoketoreductase
and aldehyde dehydrogenase (ALDH) belong to a family of several
isoenzymes important in cell defence against both exogenous and
endogenous aldehydes (Deichmann et al, 1999; Canuto et al,
2001). Compared with expression of ALDH in normal hepatocytes,
several changes were observed in rat hepatoma cells (Canuto et al,
2001). PAK-interacting exchange factor (PIX) has been reported to
mediate the recruitment of PAK into focal adhesions and thus to
create a feedback loop that stimulates PAK and other molecules
(Wang et al, 2001). Down-regulation of histon deacetylase 3 has
also been detected, as has inactivation of many tumour suppressor
genes and cell cycle regulators by methylation (Ozawa et al, 2001).
Histon deacetylase 3 was down-regulated in tumour cell lines and
may be related to the suppression of tumour suppressor genes or
cell cycle regulators. Prenatal diagnosis of multiple acyl-CoA dehy-
drogenase deﬁciency associated with elevated alpha-fetoprotein and
cystic renal change has been established (Chisholm et al, 2001). But
the precise roles of these genes in metastasis have not been identi-
ﬁed, however, so that further study is necessary.
Genes related to cell adhesion and motility
Several genes related to cell adhesion, invasion, adhesion to extra-
cellular matrix, and growth factors were abundantly over-expressed
in our cell lines derived from malignant ascites. CD44 (Hsieh et al,
1999), keratins 7 and 8 (Martens et al, 1999) are overexpressed in
several different kinds of cancers. Galectin 4 has been found to be
overexpressed in breast cancers and schirrous gastric cancer cell
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Figure 2 Northern blot analysis of differently expressed genes in eight
gastric cancer cells. Up-regulated genes in gastric cancer cells from malig-
nant ascites in comparison to primary lesion
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the speciﬁc bands of each gene
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integrin alpha 3 and beta 4 have also been reported in cancer
metastasis (Ishii et al, 2000; Chu et al, 2001; Galbiati et al,
2001). However, to our knowledge, no other reports related to
galectin 3, S100A10, desmoplakin, occludin, keratins 8, 14, myosin
VI, tubulin beta 4 and calveolin-3 in gastric cancer have been
published. Calcium binding protein S100A10 is reported to be
overexpressed in renal cell carcinoma (Teratani et al, 2002) and
may exert its effect on metastasis formation by stimulating the
motility and invasive properties of gastric cancer cells. Calveolin-
3, a muscle-speciﬁc caveolin-related protein is the principal struc-
tural protein of caveolar membrane domains, which appear to be
important for signal transduction in skeletal muscle and in the
heart (Razani et al, 2000). Keratin family genes, such as Keratins
7, 8, and 14, have different speciﬁcity, and some of them are
reportedly expressed in cancer cells to facilitate the latter’s attach-
ment to the peritoneum, and to promote liver metastasis of some
cancers. They are also known to be involved in cell migration, cell
invasiveness, plasminogen activity and drug and radiation resis-
tance (Martens et al, 1999). Myosin VI is expressed in a variety
of cell types and is thought to play a role in membrane trafﬁcking
and and endocytosis (Rock et al, 2001; Yoshimura et al, 2001).
Tubulin beta 4 is downregulated in hepatoma cells than in normal
liver cells (Yu et al, 2000). Although desmoplakin and dystroglycan
are commonly down-regulated in clinical cancer specimens, they
were overexpressed in our study (Davies et al, 1999; Henry et al,
2001). Their expression may be up-regulated again when cancer
cells are disseminated on the methelium. Whether these genes
are actually involved in peritoneal dissemination is a matter to
be further investigated.
Genes related to immunity
Down-regulation of CD4, IL2 receptor gamma and IL4–Stat
genes is extremely intriguing. CD4 and CD8 are co-receptor mole-
cules on lymphocytes and generally perform a helper or cytotoxic
function. Although loss of CD4 expression on lymphocytes is
known to correlate with the cytotoxic function, the role of CD4
expression in cancer cells remains unclear. Down-regulation of
IL4 Stat, which is an important regulator of signalling from
IL13 through the IL4R–STAT6 pathway, is necessary for down-
regulation of tumour immuno-surveillance from NKT cells. It is
reported that both IL4 and IL13 share signalling events in human
colon carcinoma cell lines (HT29 and WiDr), and that both IL13
and IL4 induce phosphorylation of IL4 STAT (STAT6) (Murata et
al, 1996; Terabe et al, 2000). The leukocyte elastase inhibitor is
one of the possible target genes of PTEN (Hong et al, 2000).
Up-regulation of leukocyte elastase inhibitor is thought to protect
cancer cells from damage by immune cells, so that weakness of
the IL13–IL4 Stat signalling pathway would allow cancer cells
to escape from the immune response of the host. FKBP54 is
known as a novel immunophilin (Milad et al, 1995; Zhu et al,
2001).
Genes related to apoptosis and cell cycle
Histone H2A is related to chromatin condensation in TGFb1-
induced apoptosis (Marushige and Marushige, 1995), while hetero-
genous nuclear ribonucleoprotein A1 seems to be related to the
potensity to develop metastases (Ghigna et al, 1998). Using COXs
as bait in the yeast two-hybrid system, we identiﬁed autoimmunity
and apoptosis-associated nucleobindin (Nuc) as a protein that
speciﬁcally interacts with both isoenzymes (Ballif et al, 1996). It
is known a reduced expression of CDK inhibitor p27 produces a
malignant phenotype of cancer cells (Porter et al, 1997; Xiangming
et al, 2000). Post-transcriptional regulation of p27 has been
reported. Although p27 down-regulation would not be speciﬁc to
peritoneal dissemination, p27 may be involved in cancer progres-
sion such as peritoneal dissemination.
Gene expression changes in adhesion molecules, signalling mole-
cules, growth factor receptors, drug metabolism and immune
response are likely to contribute to the complexicity of gastric
cancer peritoneal dissemination. Overexpression or down-regula-
tion of these genes in highly metastatic cells, as we have shown
in this study, is in good concordance with the ﬁndings of previous
reports (El-Rifai et al, 2001; Hippo et al, 2001) and indicates that
gene expression changes in these cells accurately reﬂects some
metastatic characteristics. For example, CD44 and galectin 3 (Hsieh
et al, 1999; Moon et al, 2001), genes relevant for cancer metastasis,
were up-regulated in peritoneal metastasis. Integrin b4 has recently
been reported to be a suppressor of peritoneal dissemination of
gastric cancer (Ishii et al, 2000). But our results and those of
previous reports are somewhat different, suggesting that histologi-
cal differences in samples used for these studies is responsible for
the difference in gene expression.
Although the initial discrepancy between the data obtained in
this study with high-density cDNA microarray and those obtained
with Northern blot was not negligible, the ﬁnal data presented here
were veriﬁed by two different methods and are considered be
highly reliable. cDNA microarray analysis greatly facilitated clariﬁ-
cation of a major aspect of gastric cancer metastasis by identifying
the global changes in gene expression. In this study, however, these
genes showed different expression patterns among the eight gastric
cancer cell lines, and some genes showed apparent correlation,
while others did not, with their peritoneal dissemination potential.
These results clearly show that a complex in vivo phenomenon
such as peritoneal dissemination can not be explained by altered
expression of a single gene. Thus, the relevance of exploring the
global gene expression proﬁle by using a comprehensive procedure
is obvious.
In conclusion, a combination of gene expression changes in
these genes leads to peritoneal dissemination of gastric cancers.
This implies that autocrine production of these growth factors
and their receptors by cancer cells may strongly promote invasion
and metastasis. Whether these genes are actually involved in peri-
toneal dissemination, however, is a matter to be further
investigated. A comparison between gene expression proﬁles of
highly metastatic cell lines may identify coordinate genes that func-
tion as biological markers of peritoneal dissemination. Most of the
up-regulated genes listed in Table 2 are overexpressed in most
gastric cancer cell lines, but a few genes are likely to be strongly
expressed in gastric cancer cells of peritoneal dissemination. Our
preliminary experiments indicate that at least several of the genes
listed in Table 2 were also frequently overexpressed in clinical
samples of peritoneal dissemination. Identiﬁcation of such genes
could then lead to new therapeutic modalities as well as therapeutic
targets.
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